Mounjaro

News

Lilly scores against Novo Nordisk in weight loss contest

There’s no data from a head-to-head trial directly comparing Eli Lilly and Novo Nordisk’s GLP-1 agonist drugs yet, but an observational study has found that Lilly’s tirzepatide seems to be

News

Scotland first UK nation to clear Mounjaro use for obesity

Scotland has become the first country in the UK to back NHS use of Eli Lilly’s obesity therapy Mounjaro, clearing it to assist weight management in eligible patients.

News

Lilly ups spend on diabetes, obesity drug production to $9bn

Eli Lilly is determined not to be left behind when it comes to manufacturing capacity for new diabetes and obesity therapies, raising its spending on a new plant in Indian

News

Britain will be first to get new Mounjaro device, says Lilly

Eli Lilly is just weeks away from launching Mounjaro in the UK, after getting approval from medicines regulator, the MHRA, for a new formulation of the drug as a treatment

R&D

The race for obesity drug assets heats up

The existing treatments for weight loss have drawn interest from across the industry, as their efficacy and sales potential become evident.

News

Lilly to invest $2.5bn for obesity, diabetes drug production

Eli Lilly has followed Novo Nordisk in announcing a big investment in its manufacturing network, intended to meet anticipated strong future demand for diabetes and obesity

Lilly scores against Novo Nordisk in weight loss contest

Scotland first UK nation to clear Mounjaro use for obesity

Lilly ups spend on diabetes, obesity drug production to $9bn

Britain will be first to get new Mounjaro device, says Lilly

The race for obesity drug assets heats up

Lilly to invest $2.5bn for obesity, diabetes drug production

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Mounjaro

Editor's Picks